Borrelia Burgdorferi Antibodies in Patients with Relapsing/remitting Form and Chronic Progressive Form of Multiple Sclerosis

Overview

Journal J Neurol Neurosurg Psychiatry

Publisher BMJ Publishing Group

Specialties Neurology
Neurosurgery
Psychiatry

Date 1988 Sep 1

PMID 3225603

Citations 14

Authors

E Schmutzhard

P Pohl

G Stanek

Affiliations

Soon will be listed here.

Abstract

Sera of 106 multiple sclerosis patients and 103 closely matched controls were examined for Borrelia burgdorferi antibodies. The prevalence rate in multiple sclerosis patients was 14.2%, in controls 25.2%. Overall prevalence was 20.1%. Mean IgG antibody level was insignificantly higher in controls than in multiple sclerosis patients. Patients with a chronic progressive course of multiple sclerosis had an insignificantly higher mean borrelia antibody level, when compared with those suffering from relapsing/remitting form of disease.

Citing Articles

The Probable Infectious Origin of Multiple Sclerosis.

Landry R, Embers M NeuroSci. 2024; 4(3):211-234.

PMID: 39483197 PMC: 11523707. DOI: 10.3390/neurosci4030019.

Are white matter hyperintensities associated with neuroborreliosis? The answer is twofold.

Lindland E, Rovang M, Solheim A, Andreassen S, Skarstein I, Dareez N Neuroradiology. 2024; 67(1):37-48.

PMID: 39422730 PMC: 11802615. DOI: 10.1007/s00234-024-03482-0.

Seroprevalence of Toxoplasma gondii and Borrelia burgdorferi infections in patients with multiple sclerosis in Poland.

Pawelczyk A, Donskow-Lysoniewska K, Szewczak L, Kierasinska M, Machcinska M, Rola R Sci Rep. 2024; 14(1):11015.

PMID: 38744898 PMC: 11094124. DOI: 10.1038/s41598-024-61714-y.

Bacteria-Host Interactions in Multiple Sclerosis.

Cossu D, Yokoyama K, Hattori N Front Microbiol. 2018; 9:2966.

PMID: 30564215 PMC: 6288311. DOI: 10.3389/fmicb.2018.02966.

No Geographic Correlation between Lyme Disease and Death Due to 4 Neurodegenerative Disorders, United States, 2001-2010.

Forrester J, Kugeler K, Perea A, Pastula D, Mead P Emerg Infect Dis. 2015; 21(11):2036-9.

PMID: 26488307 PMC: 4622257. DOI: 10.3201/eid2111.150778.

References

Rose A, Ellison G, Myers L, Tourtellotte W . Criteria for the clinical diagnosis of multiple sclerosis. Neurology. 1976; 26(6 PT 2):20-2. DOI: 10.1212/wnl.26.6_part_2.20. View

Paul H, GERTH H, Ackermann R . Infectiousness for humans of Ixodes ricinus containing Borrelia burgdorferi. Zentralbl Bakteriol Mikrobiol Hyg A. 1987; 263(3):473-6. DOI: 10.1016/s0176-6724(87)80113-x. View

Pachner A, Steere A . The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis. Neurology. 1985; 35(1):47-53. DOI: 10.1212/wnl.35.1.47. View

Reik Jr L, Smith L, Khan A, Nelson W . Demyelinating encephalopathy in Lyme disease. Neurology. 1985; 35(2):267-9. DOI: 10.1212/wnl.35.2.267. View

Ackermann R, Gollmer E . [Progressive Borrelia encephalomyelitis. Chronic manifestation of erythema chronicum migrans disease of the nervous system]. Dtsch Med Wochenschr. 1985; 110(26):1039-42. DOI: 10.1055/s-2008-1068956. View

Kloter I, Adam T, Schabet M, Wietholter H, PEIFFER J . Borrelia-induced meningoradiculitis--two different forms of the disease. Eur Neurol. 1986; 25(4):262-8. DOI: 10.1159/000116019. View

Kohler J, Kasper J, Kern U, Thoden U . Borrelia encephalomyelitis. Lancet. 1986; 2(8497):35. DOI: 10.1016/s0140-6736(86)92574-2. View

Gay D, Dick G . Is multiple sclerosis caused by an oral spirochaete?. Lancet. 1986; 2(8498):75-7. DOI: 10.1016/s0140-6736(86)91611-9. View

Fumarola D . Multiple sclerosis and Borrelia burgdorferi. Lancet. 1986; 2(8506):575. DOI: 10.1016/s0140-6736(86)90142-x. View

10.

Gay D, Dick G . Spirochaetes, Lyme disease, and multiple sclerosis. Lancet. 1986; 2(8508):685. DOI: 10.1016/s0140-6736(86)90189-3. View

11.

Rousseau J, Lust C, Zangerle P, Bigaignon G . Acute transverse myelitis as presenting neurological feature of Lyme disease. Lancet. 1986; 2(8517):1222-3. DOI: 10.1016/s0140-6736(86)92235-x. View

12.

Benoit P, Dournon E, Destee A, WAROT P . Spirochaetes and Lyme disease. Lancet. 1986; 2(8517):1223. DOI: 10.1016/s0140-6736(86)92236-1. View

13.

Schmutzhard E, Pohl P, Stanek G . Lyme borreliosis and multiple sclerosis. Lancet. 1987; 1(8525):167-8. DOI: 10.1016/s0140-6736(87)92009-5. View

14.

Muhlemann M, Wright D . Emerging pattern of Lyme disease in the United Kingdom and Irish Republic. Lancet. 1987; 1(8527):260-2. DOI: 10.1016/s0140-6736(87)90074-2. View

15.

Weder B, Wiedersheim P, Matter L, Steck A, Otto F . Chronic progressive neurological involvement in Borrelia burgdorferi infection. J Neurol. 1987; 234(1):40-3. DOI: 10.1007/BF00314008. View

16.

Bendig J, Ogilvie D . Severe encephalopathy associated with Lyme disease. Lancet. 1987; 1(8534):681-2. DOI: 10.1016/s0140-6736(87)90440-5. View

17.

Steere A, Bartenhagen N, Craft J, Hutchinson G, Newman J, Pachner A . Clinical manifestations of Lyme disease. Zentralbl Bakteriol Mikrobiol Hyg A. 1986; 263(1-2):201-5. DOI: 10.1016/s0176-6724(86)80123-7. View

18.

Stiernstedt G, Skoldenberg B, Garde A, Kolmodin G, Jorbeck H, Svenungsson B . Clinical manifestations of Borrelia infections of the nervous system. Zentralbl Bakteriol Mikrobiol Hyg A. 1987; 263(3):289-96. DOI: 10.1016/s0176-6724(87)80079-2. View

19.

Pachner A, Steere A . CNS manifestations of third stage Lyme disease. Zentralbl Bakteriol Mikrobiol Hyg A. 1987; 263(3):301-6. DOI: 10.1016/s0176-6724(87)80081-0. View

20.

Kristoferitsch W, Steck A, Murray N, Stanek G, Lanschutzer H . Oligoclonal antibodies in CSF of patients with meningopolyneuritis Garin-Bujadoux-Bannwarth: Ig class, light chain type and specificity. Zentralbl Bakteriol Mikrobiol Hyg A. 1987; 263(3):307-13. DOI: 10.1016/s0176-6724(87)80082-2. View